Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01587963 · ClinicalTrials.gov registry record · Phase 2
High Dose Vitamin C in the Critically Ill Patient
A Phase 2 study, sponsored by Rutgers, The State University of New Jersey.
- Terminated
- Registry status
- Phase 2
- Development phase
- 11
- Enrollment target
NCT01587963 is a Phase 2 study that was terminated before completion, run by Rutgers, The State University of New Jersey. The registered enrollment target is 11 participants.
The verdict
NCT01587963, a Phase 2 study, was terminated before completion, sponsored by Rutgers, The State University of New Jersey.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effectiveness of high doses of Vitamin C in critically ill patients.
Interventions
- DRUG Ascorbic Acid
- OTHER Ringers Lactate or Normal Saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2013-02 |
| Est. Completion | 2015-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01587963
The ClinicalTrials.gov registry entry for NCT01587963 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ascorbic Acid is the first listed.
NCT01587963 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01587963 about?
NCT01587963 is a clinical study titled "High Dose Vitamin C in the Critically Ill Patient". The purpose of this study is to determine the effectiveness of high doses of Vitamin C in critically ill patients.
What is the current status of trial NCT01587963?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 11 participants. The study started on 2013-02. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01587963?
The interventions under investigation include: Ascorbic Acid (DRUG), Ringers Lactate or Normal Saline (OTHER).
Who is sponsoring clinical trial NCT01587963?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.